Identifying effective treatments for Alzheimer's disease (AD) has proven challenging and has instigated a shift in AD research focus toward the earliest disease-initiating cellular mechanisms. A key insight has been an increase in soluble Aβ oligomers in early AD that is causally linked to neuronal and circuit hyperexcitability. However, other accumulating AD-related peptides and proteins, including those derived from the same amyloid precursor protein, such as Aη or sAPPα, and autonomously, such as tau, exhibit surprising opposing effects on circuit dynamics.
Vous voulez en lire plus?
Ouvrez une session ou inscrivez-vous pour accéder au contenu de Neurodiem.
Vous avez déjà un compte? Ouvrir une session
© 2020 Elsevier Inc